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What moves the rheumatologist? Unravelling
decision making in the referral of systemic sclerosis
patients to health professionals: a qualitative study
Juliane K. Sto¨cker1,2,3, Edith H. C. Cup4, Madelon C. Vonk3,
Frank H. J. van den Hoogen1,3, Maria W. G. Nijhuis-van der Sanden5,
J. Bart Staal2,5 and Cornelia H. M. van den Ende1,3
Abstract
Objectives. Well-coordinated multidisciplinary non-pharmacological care is considered to be a cor-
nerstone in the management of patients with systemic sclerosis. However, it has been discovered that
unmet information and health care needs are common in patients with SSc. In addition, referrals by
rheumatologists do not always correspond with potential treatment goals as identified by health profes-
sionals. The aim of this study was to gain insight into the current referral routine of rheumatologists in
SSc patients and to identify and explore factors influencing rheumatologists’ decisions about referral of
SSc patients to health professionals.
Methods. Qualitative semi-structured interviews were held with 13 rheumatologists specializing in
SSc management from different hospitals in The Netherlands.
Results. Our study identified rheumatologists’ beliefs and local policy as influencing factors for refer-
ral to health professionals and a clear need for a better referral policy. Furthermore, a lack of knowl-
edge about and low confidence in the competence of other disciplines were identified as barriers for
referral to health professionals, which may possibly lead to undertreatment.
Conclusion. In the opinion of the majority of rheumatologists, adequate referral to health professio-
nals requires an active role for the patient and increased visibility from health professionals.
Key words: beliefs, qualitative study, referral, systemic sclerosis
Introduction
SSc is a complex and rare autoimmune disease with
high morbidity and mortality [1, 2]. Prevalence estimates
vary around 20 per 100 000 [3, 4]. The main feature of
SSc is skin fibrosis, but internal organs as well as
muscles, joints and tendons can be affected as well.
SSc has a significant impact on daily functioning, partic-
ipation and quality of life [5, 6]. A large proportion of
Key messages
. The rheumatologists’ beliefs are key themes guiding referral choices for SSc.
. Low confidence of rheumatologists in the competencies of health professionals may lead to undertreatment
of SSc patients.
. A focus on pharmacological treatment may prevent a multidisciplinary approach in SSc care.
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patients experience a wide range of physical and psy-
chological symptoms, such as chronic fatigue, pain,
stiffness of joints, reduced hand function, reduced
mouth opening, depression, body image distress and
uncertainty about the future [7–10]. Pharmacological
treatment of SSc has modest to moderate efficacy in
terms of reducing morbidity and mortality, and disease-
modifying medications are scarce, if not lacking
completely [11].
In The Netherlands, non-pharmacological treatment is
often provided as an adjunct to pharmacological treat-
ment. Health professionals, such as nurses, social work-
ers, psychologists, occupational therapists, physical
therapists and podiatrists, play an important role support-
ing patients with SSc in coping with the consequences of
their disease in daily life. The majority of patients have,
on average, seven or more visits yearly to one or more
health professionals [10]. However, research on the effi-
cacy of non-pharmacological interventions for this spe-
cific patient group is sparse [12]. In her systematic review
on the effectiveness of non-pharmacologic interventions,
Willems et al. [13] found 23 studies with wide variations in
the content of interventions and outcome measures, but
just 3 studies (randomized controlled trials) met the criteria
for methodologically high quality. As a result, non-
pharmacological treatments in SSc vary widely among
health professionals with respect to treatment goals and
content of interventions [14, 15]. Unmet information and
health care needs are common among SSc patients [16].
This might be explained by the fragmented non-
pharmacological care and lack of knowledge among
physicians and patients about available treatment modali-
ties for SSc. In addition, the majority of patients are dis-
satisfied with the coordination of care [10]. Furthermore,
reasons for rheumatologists to refer SSc patients to health
professionals, mainly focusing on functional impairment,
do not correspond with the treatment goals of health pro-
fessionals, which frequently focus on the patients’ needs
concerning daily activities and participation [17]. This
implies that for SSc patients who receive care from multi-
ple providers, attention should be given to the referral pro-
cess, including communication among rheumatologists,
SSc patients and health professionals [10].
This study is the first part of an umbrella project that
aims to create transparency in the referral process of
SSc patients from rheumatologists to health professio-
nals using the view of all parties involved and to estab-
lish recommendations for improvement of the referral
process. The objective of this study is to gain insight
into the current referral routine of rheumatologists in
patients with SSc and to identify and explore factors
influencing rheumatologists’ decisions about referral of
SSc patients to health professionals.
Methods
We applied a qualitative study design using semi-
structured interviews and inductive content analysis [18].
This methodology fits within an interpretive paradigm and
enabled us to study the perspectives of specialised rheu-
matologists in terms of the SSc referral process and con-
tent. In order to report explicitly and comprehensively,
the COnsolidated criteria for REporting Qualitative re-
search checklist was used [19].
In The Netherlands, the majority of SSc patients are
treated by rheumatologists with special expertise in
SSc, appointed at several teaching and general hospi-
tals across the country [10]. In this study we aimed to
include rheumatologists with special expertise in the
management and treatment of patients with SSc. Two
scleroderma expert rheumatologists (M.V., F.H.) se-
lected colleagues with special expertise in SSc from all
rheumatologists registered in The Netherlands in August
2015 (n¼361). This resulted in a list of 24 rheumatolo-
gists. The minimum sample size for initial analysis was
set at 40% (n¼10). We applied a stopping criterion of
three, implying that data saturation is achieved after
three new interviews without new ideas emerging [20].
Potential participants were invited by e-mail to partici-
pate in the study. Rheumatologists were included in the
study after full oral informed consent, including quota-
tions used in the published article, was obtained. The
Institutional Review Board of the Radboud University
Medical Centre, Nijmegen concluded that the Medical
Research Involving Human Subjects Act did not apply to
this study (protocol number RR-157-678). The interviews
were carried out by the first investigator (J.K.S.) at each
participant’s home or workplace between September
2015 and May 2016.
Data were collected during semi-structured interviews.
The use of an interview guide (see supplementary data,
available at Rheumatology Advances in Practice online)
ensured that the main issues were addressed. Interview
questions were based on the evidence-based decision
making model in order to take the view of the rheuma-
tologist in their own context into account [21]. The semi-
structured interview guide had an open-ended format. It
focused on reasons for referring SSc patients to health
professionals or not, factors important to rheumatolo-
gists when referring SSc patients and experiences with
health professionals in daily practice.
In addition, self-reported demographic information
was recorded. The interview started with open and ex-
plorative questions about factors influencing the rheu-
matologist’s referral decisions, followed by in-depth and
probing questions to extend the responses and help
participants articulate their experiences. All interviews
lasted between 45 and 60min and were recorded digi-
tally and transcribed verbatim [22].
Qualitative data analysis followed the method of in-
ductive content analysis adapted from Nayar and
Stanley [18]. Analysis followed a six-step process of
coding to create established meaningful themes:
. Step 1: Transcribed interviews were read through sev-
eral times by the principal investigator to obtain a sense
of the whole data set.
. Step 2: Initial coding: Two investigators (J.K.S., E.C.) inde-
pendently coded the first three interviews by highlighting
Juliane K. Sto¨cker et al.
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text fragments that appeared to capture key thoughts or
concepts in relation to the research question to enhance.
Subsequently J.K.S. and E.C. discussed the procedure
and content of the analysis. J.K.S. continued to allocate
codes to remaining transcripts.
. Step 3: Grouping codes into meaningful categories
(J.K.S.).
. Step 4: The resulting categories were discussed with
two members of the project group (E.C., C.H.M.E.).
Minor adaptations were made by moving codes into
other categories. For member checking, a short de-
scription of each category was sent to the participants
and additionally to the panel of patient research part-
ners (H.K., J.T.V., J.W.) for comment. This research tri-
angulation enhanced the credibility of the findings [22].
. Step 5: The categories were grouped into meaningful
themes. In defining the themes, the researcher paid at-
tention to using the expressions of the participants in
order not to lose the original meaning of the expression.
. Step 6: The resulting themes were discussed in the
whole group of investigators until consensus was
obtained. The discussion with the research team also
enhanced the credibility.
Results
Study-wise data saturation was achieved at interview
13, as no new ideas had emerged after interview 10,
thus the scheduling of interviews ended. None of the
rheumatologists approached refused to participate or
dropped out after giving informed consent. The 13 rheu-
matologists came from nine different centres in The
Netherlands, with work experience within their specialty
ranging from 3 to 30 years (Table 1).
Two major themes, beliefs and local policy and rou-
tines, were identified as influencing decision making with
respect to referral of SSc patients to health professionals.
We also found an additional theme reflecting the needs
of the rheumatologists regarding professional multidisci-
plinary collaboration. The three themes, subthemes and
associated categories are displayed in Table 2.
Theme 1: beliefs
Beliefs about one’s own professional role
A coordinator with a helicopter view. The rheumatolo-
gist sees him/herself as a coordinator with a helicopter
view, who gives the patient guidance and structure, es-
pecially at the beginning of the treatment.
P9: ‘In principal, you are kind of the coordinating factor. . .you’re al-
most a bit of the patient’s GP. . .I do think, that as the rheumatologist
you kind of need to keep a helicopter view of all the different
aspects of what the patient is dealing with’.
They inform the SSc patient about pharmacological
and non-pharmacological treatment options and in some
cases about specific exercises. All rheumatologists ex-
press their intention to offer tailored care and are inter-
ested in seeing the patient from a holistic perspective.
Their own continuous education and professional ex-
change are considered important factors for high-quality
treatment, including evidence-based treatment options.
Beliefs about the patient’s role
Proactive patients, rheumatologist in the lead and joint
decision making. Expectations regarding the patient’s
role in the referral process vary among rheumatologists.
Some interviewees expect a very active role and feel
that the patient has a responsibility to ask for a referral
to care delivered by health professionals.
P1: ‘The responsibility really does lie with the patient, they also
need to make their own appointments, we don’t do that for them’.
Several rheumatologists see themselves in the lead.
They determine the policy for referral and propose this
to the SSc patient. Other rheumatologists draw a picture
of ‘shared responsibility’ based on the patient’s com-
plaint or request for assistance.
P6: ‘But it’s the case that I do feel it’s my duty to inform that patient
about everything that’s available. . .You’re sitting next to each other,
you hear the story, you inform them, and together you make. . .I al-
ways have the feeling that we’re making the decision together’.
All rheumatologists expect SSc patients to adhere to
agreements made and to inform them about the prog-
ress of non-pharmacological treatments they receive. In
addition, some rheumatologists mention behaviour they
find conducive to good cooperation, like the expression
of the patient’s own opinion, informing themselves prior
to the consultation or preparing a list of points to
discuss.
Rheumatologists state that SSc patients often focus
on problems related to the complexity of the disease
and their fear of potentially harmful medical examina-
tions. As a result, they forget or do not have the time to
discuss health professional treatment options.
P11: ‘If the patient has a lot of medical problems, so you have to
make medication changes. . .and the bit about multidisciplinary or
possible referral to health professionals isn’t discussed if you’ve
only got a quarter of an hour’.
Creative patients need less guidance. In several inter-
views, a distinction was made between ‘creative’ and
‘passive and uncertain’ SSc patients. Creative patients
are able to invent their own solutions to problems. It is
TABLE 1 Characteristics of the interviewed rheumatolo-
gists (n ¼ 13)
Characteristics Values
Female, n (%) 7 (54)
Age, median (range), years 35 (33–61)
Years in practice, n (%)
1–10 4 (31)
11–20 7 (54)
21 2 (15)
Working in an academic hospital, n (%) 6 (46)
SSc patients in all treated patients, % (range) 35 (5–85)
Doctoral degree, n (%) 9 (69)
Involved in research, n (%) 6 (46)
Involved in SSc guidelines development
(local or national), n (%)
6 (46)
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easier for them to grasp new knowledge and make deci-
sions about the referral process. They require less guid-
ance and explanation. With passive and uncertain
patients, the rheumatologist is more likely to propose
solutions and to determine the policy for referral.
P2: ‘You sometimes need to take the patients who demonstrate
helpless behaviour by the hand and actively show them the way.
But in general, my impression is that the prognosis for a patient
who’s active, is better’.
Patients in charge. Several rheumatologists have a vision
regarding the future role of the SSc patient as a partner
and expect them to have an active role in the treatment
process. They also have the same view with respect to their
health professional and rheumatology nurse colleagues.
They envisage a collaboration with four active parties.
P2: ‘I think the patient should also make an active contribution to his
care. . .So, I actually want there to be four active parties, and I prefer
the responsibility to lie with the patient’.
Beliefs about the role of health professionals and
rheumatology nurses
Beliefs about the role and competence of health pro-
fessionals and the effectiveness of non-pharmacological
treatments. Almost all rheumatologists stated that they
have little or no knowledge about treatment options of
health professionals. A few indicated they were familiar
with the content of treatment offered by physiothera-
pists, occupational therapists, dieticians and hand thera-
pists in their own centre. Outcome expectations varied
widely among the rheumatologists interviewed and were
based on personal experience with health professionals.
Rheumatologists with a clear structure of collaboration
and regular exchange with health professionals within
their own work setting expressed the added value of
health professional treatments.
D10: ‘An incredibly important role (health professionals). Not only in
self-management, but disease perception, being able to support
and steer where necessary. . .You will not cure the disease, but I
think it has a huge potential in maintaining quality of life’.
Rheumatologists with little experience with health profes-
sional colleagues within their own institution felt uncertain
about the effectiveness of non-pharmacological treatments.
D4: ‘I realized myself, I do not know if it helps (health professional
treatments) or whether it is coincidence or not’.
Rheumatologists with little or negative experiences with
a specific health professional did not believe in the clinical
reasoning skills of the health professionals, describing a
lack of disease-specific knowledge and poor skills regard-
ing reporting on treatment targets, content and outcome.
D6: ‘. . .and furthermore I do not refer to these health professionals
because I think they cannot do anything at all, unless there is a very
apparent reason for it’.
Beliefs about the role of the rheumatology nurse. In all
interviews, the role of the rheumatology nurse was
regarded more positively compared with other health pro-
fessionals. Their qualifications and skills are also highly
valued. All except one rheumatologist described a close
cooperation with the rheumatology nurse, ranging from
an advisory role to shared responsibility. The rheumatolo-
gist often focuses on the medical aspects and has full
confidence in the rheumatology nurse’s ability to address
the non-pharmacological and multidisciplinary aspects,
to identify problems not discussed and to give advice
about health professional treatment. Rheumatology
nurses are often seen as a key person for referrals.
In the case of new patients, the rheumatology nurse is
often involved in the intake and, later on, is the repre-
sentative of the other health professionals during multi-
disciplinary meetings. Four of the rheumatologists
TABLE 2 Themes, subthemes and categories
Themes Subthemes Categories
Beliefs Beliefs about one’s own
professional role
A coordinator with a helicopter view
Beliefs about patient’s role Proactive patients, rheumatologists in the lead and joint
decision making
Creative patients need less guidance
Patients in charge
Beliefs about the role of health
professionals and rheuma-
tology nurses
Role and effectiveness of health professionals
Role of rheumatology nurse
Local policy and
routines
Local policy, money and time
Referral to which health professional
Needs Need for active, visible health professionals
Few large expert centres exchanging expertise with regional
centres
Need for regional expert networks
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believe that, in the future, the rheumatology nurse could
play a coordinating role between rheumatologists and
other health professionals on a regular basis.
P9: ‘In fact, I refer everybody who I diagnose with scleroderma to the
rheumatology nurse. So that the nurse can give the patient more
information about the clinical picture, can tell the patient about the
challenges they’ll face in everyday life. And I do use the nurse a bit as
a guideline as to where I can further send the patient to’.
Theme 2: local policy and routines
Local policy, money and time
Local policy and, where present, care pathways have a
significant impact on the intake and referral process.
Some rheumatologists do not need to consider referral
to health professionals, because intake and advice from
all health care disciplines is part of the existing routine.
P11: ‘Actually, I must say that here we’re really connecting every-
thing to the care path, so people come every year. . .So then in fact I
don’t need to refer them, because that happens automatically’.
Due to time constraints during follow-up consulta-
tions, referrals to health professionals initiated by the
rheumatologist are mostly a result of the first consulta-
tion. Follow-up consultations are usually shorter and,
due to the complexity of the disease, focus primarily on
medical aspects. As a result, there is less attention
given to non-pharmacological care.
P11: ‘You know, if I’m really busy and my outpatient clinic runs over,
that’s also a factor that influences whether or not I remember to
mention: “Oh yeah, maybe it might be wise for you to once go back
to the occupational therapist sooner”’.
Financial aspects are taken into account when decid-
ing about referral.
P3: ‘Things that I come up against? I think mainly the payment
structure. And in particular for physiotherapy. For example, sys-
temic sclerosis isn’t covered in its chronic form. So I always discuss
with people, look at how much is covered in the insurance.
Otherwise it’s really expensive for people’.
Most rheumatologists express a clear preference for
certain health professionals when referring their patients.
This is often driven by costs, clinical pathways and inter-
nal policies with regard to referral to either hospital-based
or primary care health professionals. Another reason for
referral to a preferred therapist is trust and confidence in
the expertise of colleagues they know personally.
All centres use a centre-specific SSc intake list com-
prising medical and non-medical aspects that need to
be addressed during consultation. Often there is a more
comprehensive list for new patients, with additional
questions about work and leisure activities as possible
targets for health professional treatments.
In 11 of the 13 interviews, physical symptoms and
functional limitations were the main reason for referring
a patient to a health professional, while two rheumatolo-
gists base their decision on the actual or potential loss
of the ability to perform everyday activities or to partici-
pate in society.
P12: ‘As a rheumatologist you try to see if there are any physical
limitations. If there are any, you quickly look at how you can. . .let’s
say, try to solve it with the help of occupational therapy or
physiotherapy’.
Some rheumatologists consider non-pharmacological
treatment options only after the failure of pharmacologi-
cal treatment options.
Referral to which health professional?
Most rheumatologists regularly refer patients to physiothera-
pists and occupational therapists. Preferences for referral to
either hospital-based or primary care health professionals
differ. In general, physiotherapy in primary care is the first
option, whereas in the case of occupational therapy, referral
within the rheumatologist’s own centre is common. In many
places, referral to dieticians is defined by care pathways.
Referrals to hand therapists, dental hygienists, podiatrists,
social workers and psychologists are made on a less regu-
lar basis. Travel distance to the therapist and associated
costs and effort for the patient are also determining factors.
Theme 3: needs
The needs of the rheumatologist concern their working
environment, collaboration with health professionals and
their vision of collaboration in the future.
Need for active, visible health professionals
Generally rheumatologists express a need for sufficient
visibility of health professionals and active communica-
tion about therapy goals and treatment content. All inter-
viewees perceived a lack of published evidence on
health professional interventions.
Few large expert centres exchanging expertise with
regional centres
Due to the complexity of the disease, the rheumatolo-
gists prefer that all health care take place as close as
possible to the patient’s home environment. They be-
lieve in the importance of establishing a satellite system
of a few specialized SSc centres facilitating smaller re-
gional centres in knowledge exchange.
P5: ‘Because SSc is so rare you can actually cluster the experience and
that results in the people being treated better. Although. . .you mustn’t
specialise it that much so that people can only reach one centre with
their questions. There should at least always be a regional centre’.
Need for regional expert networks
The rheumatologists wish more interaction with health
professionals and a clear communication and collabora-
tion structure. In addition, they prefer health professio-
nals adopt a more active role in the SSc treatment
process and provide more transparency about their area
of expertise and treatment content. The latter could be
achieved through the establishment of local and regional
networks of health professionals with disease-specific
knowledge and protocols. Finally, in daily practice rheu-
matologists value transparent communication, direct or
by telephone or e-mail, and would appreciate more
structured reports.
What moves the rheumatologist?
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Discussion
This study focuses on daily routines and factors
influencing Dutch rheumatologists’ decision about the
referral of patients with SSc to health professionals. We
identified two major themes: beliefs and local policy and
routines. The additional theme reflecting the needs of
rheumatologists regarding professional multidisciplinary
collaboration is not directly related to the research ques-
tion, but rather reflects the rheumatologists’ perspective
on future challenges. As far as we know, this is the first
qualitative study focusing on the experiences of rheuma-
tologists on this specific topic.
Initially the goal of this study was to investigate fac-
tors that influence rheumatologists in their decision to
refer SSc patients to health professionals, in order to
bring transparency to their decision-making process.
However, during the analysis phase and comparison
with existing literature, it became clear that we were not
dealing with a list of distinct factors, but rather with a
complex reasoning structure underlying the rheumatolo-
gist’s decision-making process.
Rheumatologists expressed the considerable value
they attach to evidence-based practice, as well as for
the credibility of the therapy content of other disciplines.
A lack of evidence for non-pharmacological treatments
and a correspondingly low confidence in their compe-
tence was often mentioned. There is indeed little evi-
dence regarding treatments that specifically focus on
SSc [13]. However, since non-pharmacological treat-
ments often do not focus on a specific disease, but
rather on limitations in activities, there is evidence for a
large number of non-pharmacological treatments origi-
nally intended for other rheumatic conditions [23].
Therefore, in our opinion, a transfer of knowledge about
the effectiveness of non-pharmacological treatment
options could improve SSc care.
In analysing rheumatologists’ reasoning about deci-
sion making and referral we were able to distinguish the
influence of strong local policy, financial aspects and
time constraints. Our findings suggest that for referral to
health professionals, in the absence of scientific evi-
dence, rheumatologists predominantly make use of their
personal experience, beliefs and local policy. This is in
line with the rheumatologists’ decision-making routine
described by Ianello et al. [24]. These findings also un-
derpin the findings of Gabbay and le May [25] regarding
‘collectively constructed mindlines’ that are built up as a
‘bank of personalized, flexible syntheses of all the differ-
ent types of theoretical and experiential knowledge’ [24,
p. 44], and affect professionals’ reasoning and decision
making.
A common perception among the rheumatologists
was a lack of confidence in the clinical reasoning com-
petence of health professionals and their insufficient
knowledge about options of non-pharmacological treat-
ment. A strong relationship between these two factors
has also been reported by Arena et al. [26] and Suter
et al. [27]. They found that a lack of knowledge about
potential benefits is an important factor in the underuti-
lization of treatments and rehabilitation and suggest that
low perception of confidence in diagnostic and treating
competence influences the decision of whether or not to
refer a patient. On the same note, Larme and Pugh [28]
and Gallagher et al. [29] found that a combination of
lack of knowledge and a perception of low efficacy of
treatment can negatively affect the patient’s empower-
ment in their self-management.
One strength of this study is the involvement of a
panel of patient research partners, who reflected upon
and advised on the execution of the different steps of
our research.
Due to the fact that the majority of SSc patients in The
Netherlands are treated by specialized rheumatologists
working in a teaching or general hospital setting, only
those rheumatologists who, in the opinion of our two ex-
pert rheumatologists (F.H., M.V.), were considered to be
experts were included in the study. As a result, we may
have missed rheumatologists who see themselves as an
expert. Moreover, we only interviewed rheumatologists
about their opinion of the referral process. Therefore the
perspective of patients and health professionals is
missing. This means that the picture is not yet complete.
Further research will be needed to identify the perspec-
tives of all parties involved in the referral process.
Conclusions
Our study identified rheumatologists’ beliefs and local
policy as influencing factors for referral of SSc patients
to health professionals and the clear need for a better
referral policy. Furthermore, a lack of knowledge and
low confidence in the competence of other disciplines
were identified as barriers for referral to health profes-
sionals, which may possibly lead to undertreatment. The
low confidence level is closely linked to beliefs regarding
the rheumatologist’s own role as well as that of the
health professionals and SSc patients. Regular mutual
contact between rheumatologists and health professio-
nals seems to be a crucial factor in increasing confi-
dence in non-pharmacological treatment options.
In the opinion of the majority of the rheumatologists
interviewed, adequate referral to health professionals
requires an active role on the part of the SSc patient,
greater visibility of health professionals and a coordinat-
ing role of the specialized rheumatology nurse.
Funding: This study is part of the research program
for teachers with project number 023.006.043, which is
financed by the Netherlands Organization for Scientific
Research (NWO).
Disclosure statement: The authors have no conflicts of
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